Spacer
Spacer
SEARCH
Spacer
Spacer
Quotes News NAV
Spacer
Spacer
Spacer
Spacer
Spacer
Financial Ratios Markets  >  Corporate Information  >   Financial Ratios
Spacer
Rubicon Research Ltd Industry:  Pharmaceuticals - Indian - Formulations
BSE Code ISIN Demat Book Value
(R)
NSE
Symbol
Div Yield
%
Market Cap
(Rs.Cr)
P/E
(TTM)
EPS
(TTM)
Face Value
(R)
544578 INE506V01022 81.7556682 RUBICON 0.08 30,430.56 129.28 14.22 1
Your Result on : Markets | Equity | Corporate Information | Financial Ratios
ParticularsMar 2026Mar 2025Mar 2024Mar 2023Mar 2022
Debt-Equity Ratio0.340.720.960.680.31
Long Term Debt-Equity Ratio0.110.160.270.220.12
Current Ratio2.271.491.351.642.45
Fixed Assets2.352.461.641.201.42
Inventory4.314.893.623.507.01
Debtors2.152.852.641.722.06
Interest Cover Ratio9.167.512.120.422.88
PBIDTM (%)24.6126.9715.7911.1714.36
PBITM (%)21.7223.9910.252.016.48
PBDTM (%)22.2423.7710.956.3612.11
CPM (%)17.3018.589.414.8712.05
APATM (%)14.4115.603.86-4.294.17
ROCE (%)20.8226.058.611.314.68
RONW (%)18.6229.306.39-4.723.97
Spacer